Ignacio (Nacho) is a neuroscientist working at CHDI Foundation (www.chdifoundation.org) where he leads a large team of scientists developing therapeutics for Huntington's disease. A native of Spain, Ignacio lives in Los Angeles. He obtained his PhD at the Johns Hopkins University and conducted postdoctoral studies at the Rockefeller University. He is the author of over 60 scientific publications and book chapters.
Ignacio started Factor-H in 2012 together with Claudia Perandones to help Latin American families suffering from Huntington's disease.
Roger Cachope is a Colombian physician and neuroscientist who earned his Medical Doctor and Master's in Neurophysiology degrees from National University of Colombia, after which he devoted some years of clinical practice at the Central League Against Epilepsy Foundation. After postdoctoral experience in the U.S. at Albert Einstein College of Medicine and University of Maryland, Roger joined CHDI Foundation as Director of Systems Neurobiology, where he seeks to understand the brain circuitry impairments responsible for HD symptomatology, as well as the identification of potential therapeutic targets. Through Factor-H, Roger pursues to improve access from HD populations to medical care.
Phillip J. Hardt obtained his Master’s degree in English from Western New Mexico University in Computer Information Systems. He is an HD advocate who believes that every person with HD and their families deserve the highest possible quality of living while patiently waiting on a cure!
He has received many awards for service to the HD community including the HD Lighthouse “Making the Light Brighter” award in 2001 and HDSA’s “2001 Person of the Year” award his for being an example to everyone with HD. In 2001 he was selected as the HDSA Arizona Affiliate Director for 8 years were he successfully helped thousands of individuals get off the streets, onto benefits and into safe assisted-living or nursing homes. He also has directed the Arizona HD and Juvenile HD summer camps for 6 years. In October 2004, Phillip was privileged to be only one of seven individuals asked to bear testimony to the National Institutes of Health (NIH) Congressional Committee On Genetic Discrimination. He led three humanitarian missions to Juan de Acosta, Medellin and Bogota Colombia in 2006, 2007 and 2008. In December 2016 he met Nacho in Colombia and a friendship was struck up immediately.
See Philip’s work at www.philliphardt.com
Claudia Perandones is a physician specialized in Medical Genetics, and has a Master’s degree in Molecular Biology and Genetic Engineering. She completed her PhD thesis in Molecular Biology of Neurodegenerative Diseases.
She is a member of the Scientific and Technological Coordination Unit of the Board of the National Administration of Laboratories and Institutes of Health (ANLIS) “Dr. Carlos G. Malbrán,” and the Scientific Director of the Latin American Network for Huntington’s Disease (RLAH).
She has published 25 peer-reviewed papers, two books, has contributed in multiple chapters of books about movement disorders, and has received numerous awards for her scientific and humanitarian work.
Mariela Campo started Funcovulc in 2010 to bring attention to the needs of patients from the Magdalena State in Northern Colombia. This region is one of the most affected by Huntington's disease in Colombia. Mariela has a Masters' degree in social work and is an indispensable local contact. She enables, together with her volunteers, Factor-H's work in this region of Colombia. She also manages the Project Abrazos, the Kids' project, in Colombia.
Sonia Moreno is a Psychologist, Neuropsychologist and specialist in neuro-rehabilitation. She obtained her doctorate in behavioral neuroscience from the University Pablo Olavide in Spain. She has worked for over 20 years in the Neuroscience Unit at the University of Antioquia (Colombia), where her focus is on neurodegenerative indications, including HD. She is an author of 35 publications and has received numerous awards for her research work. Currently she is part of Factor-H where she works actively in improving the quality of life of patients throughout Latin America.